In January 2019, Deerfield and Yeda, the commercial arm of the Weizmann Institute of Science announced the development of an extensive translational research initiative. The research collaboration was the first outside of the USA for Deerfield and hopes to catalyze the development of transformative treatments toward clinical validation for cures for diseases and improved quality of life.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.
Read More
Investment
Supporting companies across the healthcare ecosystem with flexible funding models…
Read MoreFeatured
Genscience and Deerfield Management Announce Nature Publication Reporting Positive Impact of Genetic Evidence to Aid Discovery of More Effective Drug Targets CURE OPENS XSEED AWARD APPLICATIONS TO SUPPORT UNDERFUNDED AND UNDERREPRESENTED NYC LIFE SCIENCE STARTUPS WITH UP TO $500,000 Washington University and Deerfield Management Launch VeritaScience to Drive Drug Discovery
Portfolio Companies
Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Read More View Portfolio Companies
Research Collaborations
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.
Read More View Research Collaborations
Strategic Partners
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.
Read More
Deerfield Foundation
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.
Read More Meet the Foundation TeamFoundation Partners by Focus
Children's Health Diversity Initiatives Maternal Health View AllFounded Diversity Programs
Break into the Boardroom Fellowships Women in Science
Cure Campus
Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.
Read More Join the Cure Email ListCure Programming
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.
Events at the Cure
Porter Alliance for Innovative Medicines
In January 2022, Deerfield and Stanford University announced the creation of Porter Alliance for Innovative Medicines, a collaboration to accelerate translational research into clinical therapeutics.
Empire Deerfield Discovery and Development
In April 2021, Deerfield and Empire Discovery Institute formed a translational research partnership to accelerate the development of novel therapeutics. The company called Empire Deerfield Discovery and Development expects to translate scientific discoveries with potential applications for patients.
Hudson Heights Innovations
In June 2019, Deerfield and Columbia University announced the creation of a major research and development alliance, Hudson Heights Innovations. The collaboration is intended to advance the translation of biomedical discoveries into transformative treatments for improved quality of life and cures for diseases.
Blue Square Discoveries
In May 2021, Deerfield and Baylor College of Medicine announced a major research collaboration to advance promising therapeutics and support pharmaceutical research and discovery. The collaboration called Blue Square Discoveries will expand the resources and expertise available to Baylor to further advance discoveries beyond the laboratory.
Riverway Discoveries
In February 2021, Deerfield and Dana-Farber Cancer Institute announced the formation of a major translational research partnership, Riverway Discoveries. Riverway Discoveries plans to help accelerate the development of therapeutics and diagnostics for cancer.
Blackfan Circle Innovations
In November 2020, Deerfield and Boston Children’s Hospital, which has the largest National Institutes of Health-funded pediatric research enterprise in the United States, announced a major research collaboration, Blackfan Circle Innovations. Blackfan Circle Innovations intends to advance promising therapeutics that will address unsolved medical needs and find cures for disease.
Great Lakes Discovery
In May 2020, Deerfield and the University of Michigan announced a new partnership to create a company called Great Lakes Discovery. Great Lakes Discovery aims to commercialize therapeutic projects that hold promise in solving unmet medical needs.
Four Points Innovation
In December 2019, Deerfield and Duke University announced the creation of a major research collaboration, Four Points Innovation. Spearheaded by Duke University’s Office of Licensing & Ventures, the alliance is expected to accelerate the preclinical development of new drugs for improved quality of life and cures for diseases.
West Loop Innovations
In April 2019, Deerfield and the University of Illinois at Chicago announced the establishment of West Loop Innovations. The company will help accelerate the commercialization of therapeutics developed at UIC.